ArticleOncotarget2016

Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients.

Monica Bocchia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.